Fresenius Kabi USA, LLC – FDA 483, Feb 13, 2026
Fresenius Kabi USA, LLC, a sterile drug manufacturer in Wilson, NC, was cited for significant deficiencies across multiple quality system areas during an FDA inspection. Observations included failures in preventing microbiological contamination of sterile products, inadequate equipment cleaning and maintenance, and a systemic failure to thoroughly investigate discrepancies and batch failures. The firm also demonstrated deficiencies in quality control unit procedures, complaint handling, and maintaining segregated areas to prevent mix-ups.
ID · 82c3eb14-2c0b-4b1d-abfc-0736c844937e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.